Humanitas University
Also known as: Armando Santoro, MD | Cliniche Humanitas Gavazzeni | Fondazione Humanitas per la Ricerca | Humanitas Cancer Center - Department of Medical Oncology and Haematology | Humanitas Cancer Centre, IRCCS Humanitas Research Hospital | Humanitas Clinical and Research Center | Humanitas Clinical and Research Centre | Humanitas Clinical and Research Hospital | Humanitas Gavazzeni - Bergamo, Lombardia | Humanitas Hospital, Italy | HUMANITAS RESEARCH HOSPITAL | Humanitas Research Hospital Milan | Humanitas Research Hospital, Rozzano | Humanitas University | IBD Center, Humanitas Research Hospital, Rozzano (MI) ITALY | IBD Center, Instituto Clinico Humanitas, Department of Gastroenterology, Via Manzoni 56, 20089 Rozzano, Milan, Italy | Instituto Clinico Humanitas, Milano | IRCCS Humanitas Research Hospital | IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy
Highest phase reached
Phase 4
First clinical trial
Jun 20, 2014Last known activity
Sep 1, 2025
Timeline
2010s
- Jun 20, 2014
Humanitas University— Founded
Drugs by trial phase (54 distinct, 34 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronary Artery Disease
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Hematologic Neoplasms
- Hodgkin Disease
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Mantle-Cell
- Mesothelioma
- Nasal Polyps
- Neoplasms
- Osteoarthritis
- Osteoarthritis, Knee
- Polyps
- Small Cell Lung Carcinoma
- Thymoma
- Thymus Neoplasms
- Ulcer
Recent trials (48)
- NCT07161297Lead sponsorPhase 4Sep 1, 2025
- NCT06099171Reponsible party - principal investigatorPhase 3Feb 1, 2024
- NCT06099171Lead sponsorPhase 3Feb 1, 2024
- NCT06099171Overall official - principal investigatorPhase 3Feb 1, 2024
- NCT05883644OfficialPhase 3Jun 27, 2023
- NCT05637606Lead sponsorN/AJan 8, 2023
- NCT05637606Reponsible party - principal investigatorN/AJan 8, 2023
- NCT05637606Overall official - principal investigatorN/AJan 8, 2023
- NCT05601700CollaboratorPhase 3Sep 22, 2022
- NCT07171840Lead sponsorPhase 3May 1, 2021
- NCT07171840Sponsor investigatorPhase 3May 1, 2021
- NCT04794127CollaboratorPhase 2Apr 24, 2021
- NCT04794127Study chairPhase 2Apr 24, 2021
- NCT04853836CollaboratorPhase 4Nov 15, 2020
- NCT04426721Study chairPhase 3Jun 30, 2020
Details
- Founded
- Pieve Emanuele, IT Jun 20, 2014
- Last known activity
- Sep 1, 2025